In development: Guidance, quality standards and advice
Showing 391 to 392 of 392
Title | Type | Expected publication date |
---|---|---|
Zolbetuximab with chemotherapy for untreated claudin 18.2-positive HER2 negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinoma [ID5123] | Technology appraisal guidance | TBC |
Zuranolone for treating severe postnatal depression ID6431 | Technology appraisal guidance | TBC |